New Delhi, 29 April 2024: The Indian pharmaceutical industry needs to focus on various measures including investment in incremental innovation, market and product differentiation, cost reduction and improving efficiency, partnership for technology, market access, and risk sharing......
View Details

Related News

• HC upholds blacklisting of pharma firm for submitting forged certificate (16-05-2024)

---

• Centre sets timeline for disposing living donor transplant applications (16-05-2024)

---

• Delhi HC directs petitioners to file joint written submission on FDC ban issue (16-05-2024)

---

• Adverse events seen in some participants who took Covaxin, reports new study (16-05-2024)

---

• Centre ropes in 50 private labs to boost medical device testing (16-05-2024)

---

• CDSCO approves antibody for rare skin disorder in Indian adults (16-05-2024)

---

• DCA Cancels Smilax Pharma’s Narcotic Drug License (16-05-2024)

---

• Assam: 1000 Cough Syrup Bottles Seized, One Arrested in Kharupetia (16-05-2024)

---

• Solan: DCA under lens as drug firm didn’t disclose buyer details (15-05-2024)

---

• DCA forms Task Force to Investigate Smilax and Biogenetic Operations (15-05-2024)

---